SocraTec R&D (Germany)

Recent papers from SocraTec R&D (Germany)

1. Mechanized T-Duality and Frontier String Dynamics on K3 × T²: Closing the Loop via LeanFlow Stiff Solvers with Native Duality, Topological Data Analysis, and Lean 4 Certification2026
2. How to Optimize Healthy Volunteer Screening and Enrolment in Clinical Trials: A Qualitative and Quantitative Approach to Evaluate Processes and Healthy Volunteers' PerceptionsClinical Pharmacology & Therapeutics · 2026
3. A Weight-5 Apéry-like Binomial Sum, its Calabi–Yau 4-fold Period, and Supercongruences2026
4. SymBrain: A Biomimetic Neuro-Symbolic Architecture for Small Language Models2026
5. Biomimetic Co-Inference Learning: Bypassing Backpropagation via Telemetry-Guided Direct Feedback Alignment2026
6. Formal Verification of Memory-Safe, Symplectic Runtimes for AI Inference and Plasma Control: A Lean 4 and Logic Tensor Network Approach2026
7. A Randomized Placebo-Controlled Trial of the Efficacy and Tolerability of Etofenamate 70 mg Medicated Plaster for the Treatment of Pain in Acute Sprains, Strains or Bruises of the Soft Tissues Following Blunt TraumaPain and Therapy · 2025
8. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the sixth international EUFEPS/PQRI conferenceEuropean Journal of Pharmaceutical Sciences · 2025
9. Inhibition of ovulation and pharmacologic mechanism of action of relugolix combination therapyFertility and Sterility · 2025
10. New Ustekinumab Biosimilar Candidate FYB202: Pharmacokinetic Equivalence Demonstrated in a Randomized, Double‐Blind, Parallel‐Group, Single‐Dose Trial in Healthy SubjectsClinical Pharmacology in Drug Development · 2024
11. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conferenceEuropean Journal of Pharmaceutical Sciences · 2023
12. Heartburn relief with bicarbonate-rich mineral water: results of the randomised, placebo-controlled phase-III trial STOMACH STILLBMJ Open Gastroenterology · 2023
13. Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary SyndromesAmerican Journal of Cardiovascular Drugs · 2023
14. Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical TrialCurrent Alzheimer Research · 2022
15. Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR studyClinical and Translational Science · 2022
16. Vericiguat in Combination with Short‐Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE StudyClinical Pharmacology & Therapeutics · 2022
17. Vericiguat: a QTc interval study in patients with coronary artery diseaseEuropean Heart Journal · 2021
18. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of EUFEPS/AAPS fourth conferenceEuropean Journal of Pharmaceutical Sciences · 2021
19. Intravaginal Tolterodine Formulation Intended for Overactive Bladder Treatment—Results of a Pharmacokinetic Phase I Pilot Study in Healthy, Postmenopausal WomenClinical Pharmacology in Drug Development · 2021
20. A greener path for the EU Common Agricultural PolicyScience · 2019